AllPennyStocks.com News: Micro Cap Lining Up Several New Revenue Streams, Shares Enjoy Spectacular 2020 Gains

Mississauga, ON -- (SBWIRE) -- 09/03/2020 -- AllPennyStocks.com Media, Inc. (https://www.AllPennyStocks.com/) announces its latest article titled "Micro Cap Lining Up Several New Revenue Streams, Shares Enjoy Spectacular 2020 Gains."

Companies mentioned in this article include SoftLab9 Technologies Inc. (CSE:SOFT) (OTCPK:SOFSF), Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX).

Article Excerpt:

Apparently, nobody in government expects COVID-19 to go anywhere anytime soon. The U.S. has struck a deal to buy a minimum of 100 million doses of an experimental vaccine of Moderna (NASDAQ:MRNA) that is currently in phase 3 clinical trials. On Monday, it was disclosed that the Canadian government reached an agreement in principle with Novavax (NASDAQ:NVAX) to buy 76 million doses of its experimental vaccine, which is still in phase 2 clinical trials.

Once a vaccine finally completes clinical trials and gets regulatory approval, there is no guarantee that is the solution either. In fact, depending on which poll you choose to listen to, between 35%-50% of Americans say they will refuse to take a new COVID-19 vaccine. Rather than take a vaccine without long-term safety data, many in the population will continue with best practices to limit exposure to COVID-19.

That means long-term demand for personal protection equipment (PPE), disinfectants and other anti-viral-related products.

The full version of this article can be found at:
https://www.allpennystocks.com/specialreportsca/1441/micro-cap-lining-up-several-new-revenue-streams-shares-enjoy-spectacular-2020-gains

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.

Contact:

AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has been compensated twelve thousand dollars by the company for its efforts in presenting the SOFT profile on its web site and distributing it to its database of subscribers as well as other services. For a complete disclaimer, investors are encouraged to click here: https://www.allpennystocks.com/spotlight/58/softlab9-technologies-inc.

For more information on this press release visit: http://www.sbwire.com/press-releases/allpennystockscom-news-micro-cap-lining-up-several-new-revenue-streams-shares-enjoy-spectacular-2020-gains-1302700.htm

Media Relations Contact

Peter Szafranski
Telephone: 1-905-361-5680
Email: Click to Email Peter Szafranski
Web: https://www.allpennystocks.com/

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.